6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Runx2 deletion in smooth muscle cells inhibits vascular osteochondrogenesis and calcification but not atherosclerotic lesion formation

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <div class="section"> <a class="named-anchor" id="d1568912e213"> <!-- named anchor --> </a> <h5 class="section-title" id="d1568912e214">Aims</h5> <p id="d1568912e216">Vascular smooth muscle cells (SMCs) are major precursors contributing to osteochondrogenesis and calcification in atherosclerosis. Runt-related transcription factor-2 (Runx2) has been found essential for SMC differentiation to an osteochondrogenic phenotype and subsequent calcification <i>in vitro.</i> A recent study using a conditional targeting allele that produced a truncated Runx2 protein in SMCs of <i>ApoE</i> <sup>−/−</sup> mice showed reduced vascular calcification, likely occurring via reduction of receptor activator of nuclear factor-κB ligand (RANKL), macrophage infiltration, and atherosclerotic lesion formation. Using an improved conditional Runx2 knockout mouse model, we have elucidated new roles for SMC-specific Runx2 in arterial intimal calcification (AIC) without effects on atherosclerotic lesion size. </p> </div><div class="section"> <a class="named-anchor" id="d1568912e227"> <!-- named anchor --> </a> <h5 class="section-title" id="d1568912e228">Methods and results</h5> <p id="d1568912e230">We used an improved targeting construct to generate <i>LDLr</i> <sup>−/−</sup> mice with <i>floxed-Runx2</i> alleles ( <i>LDLr</i> <sup>−/−</sup> <i>:Runx2 <sup>f/f</sup> </i>) such that Cre-mediated recombination ( <i>LDLr</i> <sup>−/−</sup> <i>:Runx2 <sup>ΔSM</sup> </i>) does not produce functional truncated Runx2 protein, thereby avoiding off-target effects. We found that both <i>LDLr</i> <sup>−/−</sup> <i>:Runx2 <sup>f/f</sup> </i> and <i>LDLr</i> <sup>−/−</sup> <i>:Runx2 <sup>ΔSM</sup> </i> mice fed with a high fat diet developed atherosclerosis. SMC-specific Runx2 deletion did not significantly reduce atherosclerotic lesion size, macrophage number, or expression of RANKL, MCP-1, and CCR2. However, it significantly reduced AIC by 50%. Mechanistically, Sox9 and type II collagen were unaltered in vessels of <i>LDLr</i> <sup>−/−</sup> <i>:Runx2 <sup>ΔSM</sup> </i> mice compared to <i>LDLr</i> <sup>−/−</sup> <i>:Runx2 <sup>f/f</sup> </i> counterparts, while type X collagen, MMP13 and the osteoblastic marker osteocalcin were significantly reduced. </p> </div><div class="section"> <a class="named-anchor" id="d1568912e316"> <!-- named anchor --> </a> <h5 class="section-title" id="d1568912e317">Conclusions</h5> <p id="d1568912e319">SMC autonomous Runx2 is required for SMC differentiation towards osteoblast-like cells, SMC-derived chondrocyte maturation and AIC in atherosclerotic mice. These effects were independent of systemic lipid metabolism, RANKL expression, macrophage infiltration, and atheromatous lesion progression. </p> </div>

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          Functions of RANKL/RANK/OPG in bone modeling and remodeling.

          The discovery of the RANKL/RANK/OPG system in the mid 1990s for the regulation of bone resorption has led to major advances in our understanding of how bone modeling and remodeling are regulated. It had been known for many years before this discovery that osteoblastic stromal cells regulated osteoclast formation, but it had not been anticipated that they would do this through expression of members of the TNF superfamily: receptor activator of NF-kappaB ligand (RANKL) and osteoprotegerin (OPG), or that these cytokines and signaling through receptor activator of NF-kappaB (RANK) would have extensive functions beyond regulation of bone remodeling. RANKL/RANK signaling regulates osteoclast formation, activation and survival in normal bone modeling and remodeling and in a variety of pathologic conditions characterized by increased bone turnover. OPG protects bone from excessive resorption by binding to RANKL and preventing it from binding to RANK. Thus, the relative concentration of RANKL and OPG in bone is a major determinant of bone mass and strength. Here, we review our current understanding of the role of the RANKL/RANK/OPG system in bone modeling and remodeling.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study.

            Coronary calcium identified by electron-beam computed tomography (EBCT) correlates poorly with luminal atherosclerotic narrowing, but calcium, an intimate part of coronary plaque, may be more directly related to atheromatous plaque area. Thirty-eight coronary arteries from 13 autopsy hearts were dissected, straightened, and scanned with EBCT in 3-mm contiguous increments. Coronary calcium area was defined as one or more pixels with a density > 130 Hounsfield units (0.18 mm2/pixel). Each artery was divided into corresponding 3-mm segments, representative histological sections were stained, and atherosclerotic plaque area per segment (mm2) was quantified. Coronary artery calcium and coronary artery plaque areas were correlated for the hearts as a whole, for individual coronary arteries, and for individual coronary artery segments. The sums of histological plaque areas versus the sums of calcium areas were highly correlated for each heart and for each coronary artery. However, coronary plaque area was on the order of five times greater than calcium area. Furthermore, minimal diffuse segmental coronary plaque could be present despite the absence of coronary calcium detectable by EBCT. This histopathologic study confirms an intimate relation between whole heart, coronary artery, and segmental coronary atherosclerotic plaque area and EBCT coronary calcium area but suggests that there is a threshold value for plaque area below which coronary calcium is either absent or not detectable by this methodology.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Transcription factors in myeloid development: balancing differentiation with transformation.

              In recent years, great progress has been made in elucidating the progenitor-cell hierarchy of the myeloid lineage. Transcription factors have been shown to be key determinants in the orchestration of myeloid identity and differentiation fates. Most transcription factors show cell-lineage-restricted and stage-restricted expression patterns, indicating the requirement for tight regulation of their activities. Moreover, if dysregulated or mutated, these transcription factors cause the differentiation block observed in many myeloid leukaemias. Consequently, therapies designed to restore defective transcription factor functions are an attractive option in the treatment of myeloid and other human cancers.
                Bookmark

                Author and article information

                Journal
                Cardiovascular Research
                Cardiovasc Res
                Oxford University Press (OUP)
                0008-6363
                1755-3245
                October 21 2016
                November 26 2016
                : 112
                : 2
                : 606-616
                Article
                10.1093/cvr/cvw205
                5079276
                27671804
                fb9bf111-16cb-4537-87fa-628cf44e32f2
                © 2016
                History

                Comments

                Comment on this article